New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
07:01 EDTBLRXBioLineRx announces issuance of U.S. patent covering BL-8040 in immunotherapy
BioLineRx announced that an Issue of Notification has been received from the United States Patent and Trademark Office for U.S. Patent No. 8,663,651, which includes claims to protect the use of BL-8040ís composition for enhancing immune responses to an antigen, such as a tumor-associated antigen. The issued patent has a term extending to October 2029. This patent is part of BL-8040ís expanding patent portfolio, which includes 13 issued patents and 25 patent applications pending worldwide, providing a strong intellectual property estate around BL-8040.
News For BLRX From The Last 14 Days
Check below for free stories on BLRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2014
07:06 EDTBLRXBioLineRx doses first patient for BL-8040's second indication in Phase 1 trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use